retatrutide clinical trials update Tirzepatide vs. Retatrutide Phase 3: TRIUMPH Program
Description
A mitochondrial switch ("SLC25A45") controls whether mitochondria burn fat or carbohydrate, and removing it (in mice) makes GLP-1 drugs stop working for fat loss entirely

Weight loss during the first month is often modest - some patients report 2-5 pounds, others report minimal changes
People who are blind or have vision problems should not use the SEMGLEE prefilled pen without help from a person trained to use the SEMGLEE prefilled pen

We identified 137 genes with LAG-1 ChIP-seq peaks but only two of these genes are transcriptionally controlled by GLP-1 signaling/LAG-1

Wegovy is a prescription weight loss injection containing the active ingredient semaglutide
